Company Overview

Company name: ZYUS Life Sciences
Description: Developer of phytotherapeutic compounds intended to elevate cannabinoids as a standard of care and expand the potential of protein-based therapeutics in pursuit of transformational impact on patients’ lives. The company’s high-quality standardized therapeutic formulations help in the development of cannabinoids and cannabis medicines that comply with Good Manufacturing Practices (GMP) to provide targeted relief for patients, enabling patients to alleviate from suffering and restore health and wellness.
Year founded: 2018
Parent company:
Industry: Healthcare | Group: | Code:
Website: www.zyus.com
Employees: 47
City: Saskatoon
State: Saskatchewan
Country: Canada
Region:

Financial Highlights

Start up capital raised (USD Million):
Business status: Generating Revenue
Ownership: Privately Held (backing)
Exchange:
Ticker:
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period:
Financing Status:
Number of active investors:
Profile last updated: 14-dic-2020
Last known valuation:
Last known valuation date: